329. Aniridia Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 3 / Drugs : 2 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0
Drugs and their primary sponsors and trial info
Ataluren
PTC Therapeutics
2018 Phase 2 NCT04117880 -
2016 Phase 2 NCT02647359 Canada;United States;
Mitomycin
Department of Ophthalmology, Keio University School of Medicine
2013 - JPRN-UMIN000002948 Japan;
PTC Therapeutics
2018 Phase 2 NCT04117880 -
2016 Phase 2 NCT02647359 Canada;United States;
Mitomycin
Department of Ophthalmology, Keio University School of Medicine
2013 - JPRN-UMIN000002948 Japan;